The London markets closed lower as an update from AstraZeneca on its potential vaccine with the University of Oxford failed to spark life into cautious traders. AstraZeneca shares were however lower, falling 317p to 8,000p, as some analysts raised concerns that the vaccine may not get the green light in the US. Connor Campbell, financial analyst at Spreadex, said: “The AstraZeneca and Oxford vaccine update failed to recreate the kinds of gains produced by the Pfizer and Moderna preparations. Breakdown group the AA slipped in value after it confirmed it had received a £218 million offer for the business. Estate agency Countrywide jumped by 13.2p to 230p after rival Connells reconfirmed a £82.1 million offer as part of its takeover bid.

Source: Irish Independent November 23, 2020 17:59 UTC